Natural History Study for BEN
Natural History and Molecular Characterization of Benign Ethnic Neutropenia in Individuals of African Descent
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Listed as NCT00059423, this observational or N/A phase trial focuses on Agranulocytosis and Hematologic Diseases and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 16 times since 2003, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
16 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2024 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Apr 2024 [monthly]
Completed
-
Jul 2020 — Jan 2021 [monthly]
Completed
▶ Show 11 earlier versions
-
Jun 2020 — Jul 2020 [monthly]
Completed
-
May 2020 — Jun 2020 [monthly]
Completed
-
Feb 2020 — May 2020 [monthly]
Completed
-
Oct 2019 — Feb 2020 [monthly]
Completed
-
Jul 2019 — Oct 2019 [monthly]
Completed
-
Jun 2019 — Jul 2019 [monthly]
Completed
Status: Recruiting → Completed
-
Apr 2019 — Jun 2019 [monthly]
Recruiting
-
Aug 2018 — Apr 2019 [monthly]
Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jun 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
For direct contact, visit the study record on ClinicalTrials.gov .